Refine your search
2,129 results found
Knobbe Martens is an agent of innovation, providing clients worldwide with forward-focused Intellectual Property and Technology law service and…
Knobbe Martens | USA | 30 May 2023
FDA Approves Qalsody™ for Treatment of ALS
On April 25th, 2023, the U.S. Food and Drug Administration (FDA) approved QalsodyTM (tofersen) for the treatment of amyotrophic lateral sclerosis…
Knobbe Martens | USA | 30 May 2023
Brain Computer Interface Developer Announces $33M Series A, Granted FDA “Breakthrough” Designation
Brain computer interface developer Paradromics on May 18, 2023, announced a $33 million Series A funding round as well as a “Breakthrough Device…
Knobbe Martens | USA | 25 May 2023
Low-Bar for Corroboration
Medtronic filed five IPRs against patents related to catheters, relying on a single prior art reference under pre-AIA 35 U.S.C 102(e). Teleflex…
Knobbe Martens | USA | 25 May 2023
If a Case Was Baseless, It Would Have Ended Sooner
OneSubsea UK Limited and OneSubsea LLC (together “OSS”) asserted three patents against FMC Technologies, Inc. (“FMC”). The patents related to…
Knobbe Martens | USA | 22 May 2023
Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy
As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the tech industry. Though not…
Knobbe Martens | USA | 22 May 2023
Federal Circuit Review | April 2023
In Ironburg Inventions Ltd. v. Valve Corp., Appeal No. 21-2296, the Federal Circuit held that the patentee has the burden of proving that invalidity…
Knobbe Martens | USA | 12 May 2023
DuPont to Acquire Spectrum Plastics Group
DuPont announced on May 2, 2023 its acquisition of Spectrum Plastics Group (“Spectrum”), a specialty plastics manufacturer, from the private equity…
Knobbe Martens | European Union, USA | 10 May 2023
Implications of the Proposed EU Pharmaceutical Law Reform Overhaul
On April 26, 2023, the European Commission proposed a pharmaceutical law reform directed to replacing the existing pharmaceutical legislation. The…
